Where is Regeneron headed after record third quarter?
Coming off one of its strongest quarters in years, Regeneron's pipeline has seen approvals, trial fails, and promising readouts.
Coming off one of its strongest quarters in years, Regeneron's pipeline has seen approvals, trial fails, and promising readouts.